urology renal
Renal Stone Recurrence Risk Assessment
Identifies risk factors for renal stone recurrence to guide metabolic evaluation and preventive treatment.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Allopurinol · Xanthine Oxidase Inhibitor — Uric Acid Stone Prevention
- Hydrochlorothiazide · Thiazide Diuretic — Calcium Stone Prevention
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Folinic Acid (Calcium Folinate / Leucovorin) · Antidote / Chemotherapy Support
- Folinic acid (calcium folinate) · Reduced folate
- Levofolinic acid (calcium levofolinate) · Reduced folate (active enantiomer of folinic acid)
Pathways
- Acute Pyelonephritis · NICE; BAUS; RCOG — CG109, NG109
- Haematuria Assessment · NICE NG12 / BAUS 2020
- Acute Urinary Retention · EAU 2022 / NICE BPH
- Renal Colic and Ureteric Stones · EAU 2023 / NICE CG160
- Prostate Cancer Diagnosis · NICE NG131 2019
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.